Practical Approaches to Large-Scale Heterocyclic Synthesis
New practical approaches to the synthesis of complex heterocycles are reviewed.
European CDMOs Venture Into US Market
European CDMOs want into the US market, but limited options leave them on the outside, looking in.
Moving from Corrective to Preventive Actions
Enterprise quality management systems can help shift the quality emphasis from corrective to preventive actions.
Generic Drugs Face New Regulatory Future
Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.
Drug Benefit Assessment Challenges Market Access in Germany
The authors take a look at some of the recent developments in the German pharmaceutical market.
Tufts’ New Figures on Drug-Development Costs Spark Debate
Tufts research suggests costs to launch a new drug have doubled since 2003, but some question conclusions.
